This research offers crucial theoretical groundwork for the potential application of DML as a clinical therapeutic agent for PC and pioneers the exploration of the expression, function, and mechanism of MESP1, addressing a significant lacuna in PC research. The gene discussed is MESP1; the disease is pachyonychia congenita.